What is foreign policy worth if it stands disconnected from domestic realities? Make no mistake, the horrifying visuals of the human suffering in metropolitan India is only the tip of the iceberg. The vast swathes of the hinterland are heaving with untold sorrows, notes Ambassador M K Bhadrakumar.
While company executives refused to divulge further details, industry sources said that Reliance has earmarked a huge area in the SEZ for the project.
For fast-moving consumer goods, growth is likely to be tepid.
Some investors warned of a coming British or even global recession as sterling collapsed to hit its lowest since 1985.
The US Department of Health and Human Services has decided to employ 10 full-time officials in Delhi -- a country director, four drug inspectors, two senior technical experts in medicines, two technical experts in medical devices and one from the food sector. 'The purpose of the appointment is to help develop food and medical product regulations and agencies improve product safety and conduct inspections in a more timely manner,' said Christopher Kelly, press officer, USFDA.
If Walmart is spinning success stories of Indian manufacturers in global markets, Amazon is taking 'Make in India' to the world, bolstered by its 'Global Selling Programme'
COVID-19 has emerged as an important form of diplomatic currency around the world as nations try to showcase their soft power gains. In this race, India has an edge as India is already a pharmaceutical giant having produced some 60 per cent of global vaccines and now justly seeking to strengthen ties and expand its influence in its neighbourhood and beyond, observes Dr Rajaram Panda.
The EU is challenging the introduction of import duties on a wide range of ICT products, for instance mobile phones and components, base stations, integrated circuits and optical instruments
The United States 'is leading the world in the use of compulsory licenses, and is hypocritical in voicing indignance when developing countries issue compulsory licenses for essential drugs,' Washington-based Knowledge Ecology International, with its offices in Geneva, has alleged.
'The coronavirus epidemic highlights the need to start thinking more actively about multilateral coordination, including, but not confined to, health emergencies and climate uncertainties,' says Rathin Roy.
Ajit Mishra, vice president, Research, Religare Broking, answers your queries.
Low growth visibility and trouble with regulators have resulted in lack of interest from investors
Devangshu Datta highlights the silver lining for the long-term investor.
The pharmaceutical industry is expected to continue with its good performance in the first quarter of 2008-09 with over 25 per cent growth in revenues and about 45 per cent rise in net profit riding on better sales in the domestic and export markets. The industry will gain from the the depreciation of rupee as well.
'The ban on Chinese imports is a suicidal step.' 'This will result not only in economic depression, but in a chaotic situation.'
The FDA has stepped up its efforts to ensure drug safety in recent months.
The NSE Nifty after shuttling between 10,441.90 and 10,341.90, ended 6.15 points, or 0.06 per cent down at 10,380.45.
Neither pharma nor IT would have become the stars of the economy without the active but largely invisible hand of the Indian State, says Ajit Balakrishnan.
India on Monday raised serious concerns over the USFDA's audit inspections of Indian pharma companies and 'disproportionate penalties' in some instances and said it would submit a discussion document on the issues to the US.
India's GDP growth for the current fiscal is expected to slow down to 4.8 per cent, a UN report has said, warning that the Covid-19 pandemic is expected to result in significant adverse economic impacts globally. The UN 'Economic and Social Survey of Asia and the Pacific (ESCAP) 2020: Towards sustainable economies' said that Covid-19 is having far-reaching economic and social consequences for the region, with strong cross-border spillover effects through trade, tourism and financial linkages.
With financial results for the quarter round the corner, small- and medium-sized, export-oriented pharmaceutical companies are expecting a 5-10 per cent decline in their bottom line for the April-June period, owing to the rupee appreciation.
During the webinar, 'COVID-19: Vaccination and Potential Return to Normalcy - If and When', Dr Hotez, an internationally-recognised physician-scientist in neglected tropical diseases and vaccine development, said that the COVID-19 vaccine rollout is "India's gift' to the world in combating the virus.
Ajit Mishra, vice president, Research, Religare Broking, answers your stock market queries.
Under Railways, the two sides agreed to pursue specific collaboration arrangements in heavy haul, station redevelopment and raising speed of existing trains in India.
The other sectors where inflows have declined include pharmaceuticals ( $680 million).
RBI Governor Raghuram Rajan expressed anguish at the banks' reluctance to pass on benefits of the earlier rate cuts.
Indian firms feared they would lose business if US ratified the Trans-Pacific Partnership agreement with 11 other countries.
'China feels India will be hard-pressed not to go after China because we are so badly dependent on them -- and that is the reality.'
DCGI, health ministry initiate dialogues with foreign regulators, try to understand global best practices
'I hope the trend is sustainable and that economic activity accelerates going forward.'
Experts say the stock market correction in recent times increases the risk-reward in favour of large-cap stocks.
'Since the bilateral deficit is a reality -- and a worry -- we need to find a way to deal with it,' says Ravi Bhoothalingam.
Rating agency Crisil said corporates, especially those in the auto, aviation, consumer durables and oil sectors, will be "severely impacted" by rupee depreciation due to large overseas debt and limited hedging.
India could offer a train track to China to run a bullet train besides easy terms to set up industrial parks.
Data also show that several other leading domestic pharma companies have recalled their products from the US
